Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
1-15 of 2993 results
BioGX launches six CE-Mark tests for meningitis and antibiotic resistance
BioGX has launched six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX Sample-to-Answer platform.
Diagnostics > In Vitro Diagnostics > News
Agilent launches real-time, live-cell ATP Rate assay kit
Agilent Technologies has introduced Agilent Seahorse XF Real-Time ATP Rate Assay Kit, a new product that will allow biologists to improve their understanding of how live-cells function in real-time.
Diagnostics > In Vitro Diagnostics > News
Gilead, Verily announce inflammatory disease collaboration
By MDBR Staff Writer
Gilead Sciences and Alphabet company Verily Life Sciences have partnered to identify and understand immunological and molecular drivers of inflammatory diseases.
Diagnostics > In Vitro Diagnostics > News
Seegene to unveil combination test at ECCMID 2018
Multiplex PCR technologies developer Seegene will introduce the combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018), which will take place in Madrid, Spain, from 21 April to 24 April.
Diagnostics > In Vitro Diagnostics > News
Abionic secures funding to expand portfolio of point-of-care IVD tests
By MDBR Staff Writer
Abionic has raised CHF20m ($21m) series C financing to expand its portfolio of point-of-care IVD tests for critical care and emergency medicine.
Diagnostics > In Vitro Diagnostics > News
Ortho Clinical Diagnostics introduces Ortho's VITROS C-peptide assay
Ortho Clinical Diagnostics has launched Ortho's VITROS® Immunodiagnostic Products C-peptide Reagent Pack and Calibrators, expanding the firm’s menu of tests for all aspects of diabetes and other pancreatic disorders.
Diagnostics > In Vitro Diagnostics > News
Quidel gets FDA nod to market Sofia Lyme FIA with Sofia 2 instrument
Quidel has received 510(k) clearance from the US Food and Drug Administration (FDA) for its point-of-care Sofia Lyme fluorescent immunoassay (FIA) for use with Sofia 2 instrument.
Diagnostics > In Vitro Diagnostics > News
Genomic Health launches Oncotype DX AR-V7 Nucleus Detect test
Genomic Health has commercially launched the Oncotype DX AR-V7 Nucleus Detect test in the US.
Diagnostics > In Vitro Diagnostics > News
FDA approves Banyan Biomarkers’ diagnostic blood test for traumatic brain injury
By MDBR Staff Writer
Banyan Biomarkers has secured marketing approval from the US Food and Drug Administration (FDA) for the first in vitro diagnostic blood test for traumatic brain injury (TBI).
Diagnostics > In Vitro Diagnostics > News
Anitoa launches ultra-portable qPCR system
Anitoa Systems has introduced Maverick, an ultra-portable quantitative-polymerase-chain-reaction (qPCR) system.
Diagnostics > In Vitro Diagnostics > News
Qiagen gets Japanese approval for QuantiFERON-TB Gold Plus in vitro diagnostic test
Qiagen has secured approval from the Japan’s Ministry of Health Labor and Welfare for QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.
Diagnostics > In Vitro Diagnostics > News
Abbott supports Angle's breast cancer liquid biopsy study
By MDBR Staff Writer
Healthcare firm Abbott will provide its PathVysion HER-2 DNA FISH probe kits for use in Angle's breast cancer liquid biopsy study.
Diagnostics > In Vitro Diagnostics > News
Siemens Healthineers gets FDA clearance for blood urea nitrogen and total C02 point-of-care testing
Siemens Healthineers announced has received 510(k) clearance from the US Food and Drug Administration for its blood urea nitrogen (BUN) and total carbon dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Diagnostics > In Vitro Diagnostics > News
Pfizer, Foundation Medicine to develop companion diagnostics for oncology treatments
By MDBR Staff Writer
Pfizer has collaborated with Foundation Medicine for the development of companion diagnostics (CDx) for its oncology portfolio.
Diagnostics > In Vitro Diagnostics > News
GE, Roche partner to develop clinical decision support software
GE Healthcare and Roche have partnered to develop integrated digital diagnostics platform to enhance oncology and critical care treatment.
Diagnostics > In Vitro Diagnostics > News
1-15 of 2993 results